TABLE 2.
Expt no. | Marker distance (bp) | No. of cells
|
MOI
|
% of TMMRRb | ||||
---|---|---|---|---|---|---|---|---|
Total | Infected | GFP+ | Infection | GFP | GFP/infectiona | |||
1 | 90 | 240,821 | 71,193 | 2,335 | 0.350 | 0.0097 | 2.8 | 22.2 |
288 | 285,101 | 52,246 | 3,070 | 0.202 | 0.0108 | 5.3 | 42.8 | |
588 | 261,476 | 100,252 | 9,822 | 0.484 | 0.0383 | 7.9 | 63.3 | |
2 | 90 | 198,984 | 70,998 | 2,485 | 0.441 | 0.0125 | 2.8 | 22.7 |
288 | 45,436 | 12,328 | 801 | 0.317 | 0.0178 | 5.6 | 44.9 | |
588 | 295,208 | 123,450 | 12,298 | 0.542 | 0.0425 | 7.8 | 62.7 | |
3 | 90 | 225,247 | 40,055 | 1,149 | 0.196 | 0.0051 | 2.6 | 20.8 |
288 | 198,666 | 58,191 | 4,004 | 0.347 | 0.0204 | 5.9 | 47.0 | |
588 | 229,025 | 64,002 | 5,634 | 0.328 | 0.0249 | 7.6 | 60.7 |
Means ± standard deviations for markers separated by the indicated distances were as follows: 90 bp, 2.7 ± 0.1; 288 bp, 5.6 ± 0.2; 588 bp, 7.8 ± 0.1.
Means ± standard deviations for markers separated by the indicated distances were as follows: 90 bp, 21.9% ± 0.8%; 288 bp, 44.9% ± 1.7%; 588 bp, 62.4% ± 1.3%.